Fluanxol 0,5 & 1 mg FC tablets
PDF Leaflet Revision Date: 23 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of mild to moderate depression.
Dosage (summary)
Adults: Initial 1 mg daily, may increase to 2 mg after 1 week; max 3 mg. Elderly: 0.5 - 1.5 mg daily.
Onset of Action / Duration
Onset: 2-3 days, Duration: Not specified.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding; may cause neonatal withdrawal symptoms.
Key Drug Interactions
- CNS depressants
- Lithium
- Tricyclic antidepressants
- Antihypertensives
Contraindications
- Hypersensitivity to flupenthixol
- Severe depression requiring ECT
- CNS depression
- Coma
Common side effects
- Somnolence
- Tachycardia
- Dry mouth
- Dizziness
- Fatigue
Counselling Points
- Monitor for suicidal thoughts
- Avoid alcohol
- Regular eye exams recommended
Serious warnings
- QT prolongation
- Increased risk of suicidal thoughts
- Neuroleptic malignant syndrome
Important Disclaimer
The Fluanxol 0,5 & 1 mg FC tablets professional information leaflet below is the property of HLundbeck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
